French Atomic Energy Commission

The French Atomic Energy Commission (CEA) is a technological and fundamental research body, employing 15.000 people on research on energy and technology for information and health. The Life Sciences Division of the CEA employs more than 1300 people, and one of its major interests is in neurodegenerative diseases, oncology and biomedical imaging. In these fields the research approaches go from fundamental exploration of the functions of the brain, methodological research for new imaging systems (TEP with specific tracers, very high field NMR imaging.) and preclinical and clinical research. Its researchers publish around 700 papers per year, with an average impact factor above 5. It has more than 100 patents in the field of life sciences and biotechnology, and numerous contracts with the industry (pharmaceutical, diagnosis, medical devices and more). The CEA and its Biomedical Imaging Institute I²BM (including Service hospitalier Frédéric Joliot in Orsay, Mircen in Fontenay aux Roses, and NeuroSpin, a very high field NMR facility for imaging the brain, in Saclay) is very strongly involved in the worldwide competitivity cluster Medicen (on technology for health), and in structuring national and regional research networks (academic and translational) in neurosciences.

To CEA's website

Lucie Hertz-Pannier National coordinator